 control is often not indicated in people with PAD and a DFU due to the risk of
hypoglycaemia outweighing the potential beneÔ¨Åt. The
ADA recommends in the 2022 Standards of Care to aim
for an HbA1c < 8% (< 64 mmol/mol) in such persons and
the ESC-EASD 2019 guideline for levels below 8 e 9%
(< 64 e 7